Abstract: An alginate fibre is provided which includes one or more medicaments incorporated into the fibre core such that the one or more medicaments can be released in a sustained manner over time and, optionally, one or more medicaments attached to the surface of the fibre whereby the one or more medicaments attached to the surface of the fibre can be released rapidly therefrom.
Type:
Grant
Filed:
November 22, 1994
Date of Patent:
November 25, 1997
Assignee:
E. R. Squibb & Sons, Inc.
Inventors:
Bryan Griffiths, Pter Michael John Mahoney
Abstract: Methods and devices for preventing and/or treating an adverse reaction of the skin to the presence of a skin-sensitizing and/or skin-irritating agent by administering an effective amount of a loop diuretic alone or in combination with at least one mast cell degranulator or at least one glucocorticosteroid.
Abstract: In accordance with the present invention a novel wound dressing providing superior absorption and preventing leakage is disclosed. The present dressing comprises a hydrocolloid-containing polymeric support layer either continuous or non-continuous and an occlusive backing layer overlying the support. In a preferred embodiment the present dressing further includes an adhesive on a skin-contacting surface of the support and an absorbent region interposed between the support and the backing layer.
Abstract: The present invention relates to a preserved, yet non-cytotoxic alginate based hydrating gel system for the purpose of treating wounds that need moisture. Sodium carboxymethylcellulose and an alginate polymer blend impart sufficient viscosity to an aqueous solution to provide moisture to the wound. The blend reduces the cytotoxicity of a combination of preservatives incorporated into the system. More specifically, the invention relates to a wound hydrating gel comprising a) a hydrocolloid mixture of carboxymethylcellulose and sodium/calcium alginate, and b) a preservative system. This invention further relates to methods of preparing and using the wound hydrating gel.
Type:
Grant
Filed:
December 20, 1993
Date of Patent:
September 23, 1997
Assignee:
E.R. Squibb & Sons, Inc.
Inventors:
Marc D. Cornell, Nancy E. Kaiser, Rita A. Brenden
Abstract: In accordance with the present invention novel methods for cardiopulmonary bypass and organ transplant, each employing a potassium channel activator, are disclosed. The use of a potassium channel activator has been found to reduce the damage or ischemia induced by the bypass and transplant procedures.
Abstract: Methods and devices for preventing an adverse reaction of the skin to the presence of a skin-sensitizing agent by administering an effective amount of a potassium-sparing diuretic.
Type:
Grant
Filed:
November 22, 1994
Date of Patent:
April 8, 1997
Assignee:
E.R. Squibb & Sons, Inc.
Inventors:
John J. Wille, Agis Kydonieus, Frank S. Castellana
Abstract: A novel device and method for the application of two or more components of a fibrin sealant using a gas is disclosed. The novel device and method involve the concentric arrangement of annular apertures for each of the components concentric with and radially outward of a center gas discharge aperture in the exit end of a spray head. Reservoirs for each component, for example syringe cartridges or cylinders, are in dextrete fluid communication with the spray head and preferably can be activated by a common means.
Abstract: A novel two piece dressing having a baseplate and wound fluid absorbing material is provided according to the present invention. The baseplate is provided with slits or incisions for covering, examining and/or treating the wound without removing the baseplate. The dressing contains an absorbent material designed to remove excess exudate from the wound through an aperture in the baseplate. The incisions or slits may, in one embodiment, extend from the aperture and define one or more flaps for viewing and/or treating the wound.
Abstract: In a process of separating a liquid sample having phase portions of different densities by centrifugal separation, a phase separator container is employed. The phase separator container comprises a housing having concentric inner and outer cylindrical walls defining a longitudinal axis and a top wall and further a piston body constituting a bottom wall of the housing. The piston body defines together with the outer cylindrical wall, the inner cylindrical wall and the top wall, an annular chamber for receiving the liquid sample. The piston body is displaceable within the annular chamber for draining a phase portion separated from the liquid sample through a drain conduit means communicating with the annular chamber. The phase separation chamber further comprises a reaction chamber to which the phase portions exposed from the annular chamber is processed.
Abstract: In accordance with the present invention novel medical dressing systems and methods are disclosed using a semiperipheral support design which provides at least one conformal, unsupported dressing edge upon application. The dressing system disclosed herein comprises a backing layer, an adhesive material overlying the backing layer and a release liner overlying the adhesive, wherein said medical dressing system further comprises a final dressing portion and a semiperipheral support portion partially surrounding said dressing portion and said support portion being partially defined by a separation, said dressing portion being further defined by at least one unsupported edge, said one or more unsupported edges extending from a first end to a second end of said semiperipheral support portion.
Abstract: Pressure-sensitive adhesives which possess absorptivity and/or permeability properties to remove transepidermal water loss and/or other bodily fluids that come into contact with the adhesive, in combination with a fine balance of cohesion and adhesion properties, can be formulated by controlling the crosslinking of a polyurethane polymer having excess hydroxyl functionality, a glass transition temperature of less than about 0.degree. C., a moisture absorption of at least about 20% of its weight and/or a moisture vapor transmission rate of at least about 300 grams/meter.sup.2 /24 hours measured at 37.degree. C. and a 90% relative humidity gradient. Adhesives of these polymers possess a peel adhesion to human skin of between about 0.3 and 4 newtons/cm width of the polymer or adhesive.
Type:
Grant
Filed:
May 9, 1995
Date of Patent:
January 7, 1997
Assignee:
E. R. Squibb & Sons, Inc.
Inventors:
Agis Kydonieus, Ladislav Bastar, Kishore Shah, Khosrow Jamshidi, Tak-lung Chang, Sheng-hung Kuo
Abstract: A polymeric device for the controlled release of active agents contained in the device in which the polymer has a glass transition temperature greater than the normal storage or non use temperature of the device. When heated to or above the glass transition temperature of the polymer, the active agent is released. The release of active agent can be switched on or off by the adjustment of the temperature of the polymeric device above or below the glass transition temperature of the polymer.
Type:
Grant
Filed:
July 7, 1993
Date of Patent:
December 3, 1996
Assignee:
E. R. Squibb and Sons, Inc.
Inventors:
Agis Kydonieus, Kishore R. Shah, Stefanie C. Decker
Abstract: Novel compounds are disclosed having the formula ##STR1## and R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6 and R.sub.7 are as defined herein. These compounds are useful, for example, as cardiovascular agents and especially as anti-ischemic agents.
Abstract: A composite material for wound dressings having a fibrous wound-contacting substrate, such as cotton gauze, impregnated with a thermoplastic hydrogel forming polymer and methods of making the same.
Type:
Grant
Filed:
March 30, 1994
Date of Patent:
June 18, 1996
Assignee:
Bristol-Myers Squibb Co.
Inventors:
Kishore R. Shah, Agis Kydonieus, Khosrow Jamshidi, Stefanie C. Decker, Tak-lung Chang
Abstract: Novel compounds having potassium channel activating activity and useful, for example, as antiischemic agents are disclosed. These compounds have the general formula ##STR1## wherein A is ##STR2## or a single bond to complete an indoline nucleus; X is --O--, --S-- or --NCN; and the R groups are as defined herein.
Abstract: A hydrocolloid wound gel composition useful for cleansing an debriding wounds and having some capacity for absorbing wound exudate and a method of treating wounds comprising applying the hydrocolloid wound gel to a wound.The composition includes sodium carboxymethylcellulose, pectin, propylene glycol and water.
Type:
Grant
Filed:
April 15, 1993
Date of Patent:
April 2, 1996
Assignee:
E. R. Squibb and Sons, Inc.
Inventors:
Douglas Queen, Lesley A. Chambers, Simon M. Adams, Hugh Delargy
Abstract: A two stage method using the same container for both cleaning and microbiologically decontaminating grossly soiled surgical instruments is described. A presoak in an enzyme solution is followed by direct addition of a compatible disinfectant and a continued soak to decontaminate surgical instruments and other paraphernalia used in healthcare facilities.
Abstract: Novel A-II receptor antagonists have the formula ##STR1## and its isomer ##STR2## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7 and R.sub.8 are as defined herein.
Abstract: A new method for the treatment of ischemia conditions and arrhythmia is disclosed. The method uses compounds of the formula ##STR1## wherein A can be --CH.sub.2 --, --O--, --NR.sub.9 --, --S--, --SO--, --SO.sub.2 --; X can be oxygen or sulfur; Y can be --NR.sub.8, --O--, --S--, --CH.sub.2 -- and the R groups are as defined herein. Novel compounds within the definition of formula I are also disclosed.